[II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome].
作者信息
Shimada Yasuhiro
机构信息
Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
出版信息
Gan To Kagaku Ryoho. 2012 Nov;39(11):1646-9.
PMID:23243702
Abstract
摘要
相似文献
1
[II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome].
Gan To Kagaku Ryoho. 2012 Nov;39(11):1646-9.
2
[II. Postoperative adjuvant chemotherapy for colon cancer. 1. Is oxaliplatin combination the most effective chemotherapy for colon cancer?].
Gan To Kagaku Ryoho. 2012 Nov;39(11):1642-.
3
Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Nat Clin Pract Oncol. 2008 Feb;5(2):72-3. doi: 10.1038/ncponc1006.
4
Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
Oncology (Williston Park). 2004 Sep;18(10):1313.
5
FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691.
6
Oxaliplatin in the adjuvant treatment of colon cancer.
CA Cancer J Clin. 2012 Jan-Feb;62(1):3-4. doi: 10.3322/caac.21131. Epub 2011 Nov 16.
7
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24.
8
Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
Prescrire Int. 2006 Jun;15(83):109-1.
9
[Lower G. I./colon and rectum cancer. III. Current topics concerning postoperative adjuvant chemotherapy].
Gan To Kagaku Ryoho. 2010 Nov;37(11):2080-4.
10
The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer.
J BUON. 2011 Oct-Dec;16(4):682-8.
Zotero 插件